Complementary analysis of genomic and epigenomic features in plasma and urinary cell-free DNA for risk stratification in prostate cancer at first diagnosis

Documenti analoghi

• Complementary analysis of genomic and epigenomic features in plasma and urinary cell-free DNA for risk stratification in prostate cancer at first diagnosis
  di: Riediger, Anja Lisa
  Pubblicazione: (2026)
• Multimodal plasma and urinary cell-free DNA profiling improves risk stratification in newly diagnosed prostate cancer
  di: Riediger, Anja Lisa, et al.
  Pubblicazione: (2026)
• Bisulfite-free epigenomics and genomics of single cells through methylation-sensitive restriction
  di: Niemöller, Christoph, et al.
  Pubblicazione: (2021)
• Biomarkers for the detection and risk stratification of aggressive prostate cancer
  di: Eickelschulte, Samaneh, et al.
  Pubblicazione: (2022)
• Cell-free DNA as a complementary marker of therapeutic futility in adenoid cystic carcinoma
  di: Blocka, Joanna, et al.
  Pubblicazione: (2025)